Twist Bioscience Corporation (TWST)
NASDAQ: TWST · IEX Real-Time Price · USD
47.32
-1.61 (-3.29%)
At close: Jul 2, 2024, 4:00 PM
47.90
+0.58 (1.23%)
After-hours: Jul 2, 2024, 7:38 PM EDT
Twist Bioscience Market Cap
Twist Bioscience has a market cap or net worth of $2.76 billion as of July 2, 2024. Its market cap has increased by 179.01% in one year.
Market Cap
2.76B
Enterprise Value
2.55B
1-Year Change
179.01%
Ranking
Category
Stock Price
$47.32
Market Cap Chart
Since October 31, 2018, Twist Bioscience's market cap has increased from $372.50M to $2.76B, an increase of 639.67%. That is a compound annual growth rate of 42.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 2.85B | 34.01% |
| Dec 29, 2023 | 2.13B | 57.84% |
| Dec 30, 2022 | 1.35B | -64.93% |
| Dec 31, 2021 | 3.84B | -39.79% |
| Dec 31, 2020 | 6.38B | 817.27% |
| Dec 31, 2019 | 695.50M | 7.78% |
| Dec 31, 2018 | 645.30M | 73.23% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arcellx | 2.95B |
| Xenon Pharmaceuticals | 2.94B |
| Amicus Therapeutics | 2.94B |
| GoodRx Holdings | 2.93B |
| ICU Medical | 2.89B |
| Envista Holdings | 2.86B |
| Azenta | 2.84B |
| Inari Medical | 2.80B |